This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications鈥�
- Investigator
- Karen Daily
- Ages
- 18 Years - N/A
- Sexes
- All